|Articles|February 2, 2003
- Pharmaceutical Technology-02-02-2003
- Volume 27
- Issue 2
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Author(s)Michael Mitchell
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.
Advertisement
Articles in this issue
almost 23 years ago
A Stress Testing Benchmarking Studyalmost 23 years ago
Cleanroom Pressurization Methodologyalmost 23 years ago
Manufacturing Capability Key to Global Health Advancesalmost 23 years ago
February 2003almost 23 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs
2
The Shift from Containment to Protection: Packaging Trends Impacting Pharma
3
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
4
Ask the Expert: Collaboration Ensures Effective Procurement
5